Use the Back button in your browser to see the other results of your search or to select another record.
Multicenter osteopathic pneumonia study in the elderly: subgroup analysis on hospital length of stay, ventilator-dependent respiratory failure rate, and in-hospital mortality rate |
Noll DR, Degenhardt BF, Johnson JC |
The Journal of the American Osteopathic Association 2016 Sep;116(9):574-587 |
clinical trial |
5/10 [Eligibility criteria: No; Random allocation: Yes; Concealed allocation: No; Baseline comparability: Yes; Blind subjects: No; Blind therapists: No; Blind assessors: No; Adequate follow-up: No; Intention-to-treat analysis: Yes; Between-group comparisons: Yes; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed* |
CONTEXT: Osteopathic manipulative treatment (OMT) is a promising adjunctive treatment for older adults hospitalized for pneumonia. OBJECTIVE: To report subgroup analyses from the Multicenter Osteopathic Pneumonia Study in the Elderly (MOPSE) relating to hospital length of stay (LOS), ventilator-dependent respiratory failure rate, and in-hospital mortality rate. DESIGN: Multicenter randomized controlled trial. SETTING: Seven community hospitals. PARTICIPANTS: Three hundred eighty-seven patients aged 50 years or older who met specific criteria for pneumonia on hospital admission. INTERVENTIONS: Participants were randomly assigned to 1 of 3 groups that received an adjunctive OMT protocol (n = 130), a light touch (LT) protocol (n = 124), or conventional care only (CCO) (n = 133). MAIN OUTCOME MEASURES: Outcomes for subgroup analyses were LOS, ventilator-dependent respiratory failure rate, and in-hospital mortality rate. Subgroups were age (50 to 74 years or >= 75 years), Pneumonia Severity Index (PSI) class (I to II, III, IV, or V), and type of pneumonia (community-acquired or nursing-home acquired). Data were analyzed by intention-to-treat and per-protocol analyses using stratified Cox proportional hazards models and Cochran-Mantel-Haenszel tests for general association. RESULTS: By per-protocol analysis of the younger age subgroup, LOS was shorter for the OMT group (median 2.9 days; n = 43) than the LT (median 3.7 days; n = 45) and CCO (median 4.0 days; n = 65) groups (p = 0.006). By intention-to-treat analysis of the older age subgroup, in-hospital mortality rates were lower for the OMT (1 of 66 (2%)) and LT (2 of 68 (3%)) groups than the CCO group (9 of 67 (13%)) (p = 0.005). By per-protocol analysis of the PSI class IV subgroup, the OMT group had a shorter LOS than the CCO group (median 3.8 days (n = 40) versus 5.0 days (n = 50); p = 0.01) and a lower ventilator-dependent respiratory failure rate than the CCO group (0 of 40 (0%) versus 5 of 50 (10%); p = 0.05). By intention-to-treat analysis, in-hospital mortality rates in the PSI class V subgroup were lower (p = 0.05) for the OMT group (1 of 22 (5%)) than the CCO group (6 of 19 (32%)) but not the LT group (2 of 15 (13%)). CONCLUSION: Subgroup analyses suggested adjunctive OMT for pneumonia reduced LOS in adults aged 50 to 74 years and lowered in-hospital mortality rates in adults aged 75 years or older. Adjunctive OMT may also reduce LOS and in-hospital mortality rates in older adults with more severe pneumonia. Interestingly, LT also reduced in-hospital mortality rates in adults aged 75 years or older relative to CCO. (ClinicalTrials.gov number NCT00258661).
|